课题基金 / 基金详情

AHR as a master regulator in cutaneous and systemic autoimmunity

AHR as a master regulator in cutaneous and systemic autoimmunity
AHR 作为皮肤和全身自身免疫的主要调节剂
批准号:
511931885
负责人:
Professorin Dr. Karin Loser
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Units
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Professorin Dr. Karin Loser的其他基金

相似基金

相关文献

中文摘要
翻译
系统性红斑狼疮(SLE)是一种慢性自身免疫性疾病,影响许多器官,包括皮肤,关节,中枢神经系统或肾脏。尽管SLE的病理生理学尚未完全了解,但已显示受损的细胞凋亡清除、上调的先天性和适应性免疫应答、补体激活、自身抗体和促炎细胞因子(包括1型干扰素)的不平衡产生的相互作用导致自身耐受性的丧失。SLE的发病需要遗传易感性、环境触发因素、免疫因素以及激素因素的组合。在SLE的环境触发因素中,紫外线(UV)光是最公认的一种。紫外线照射有助于色氨酸光产物的产生,色氨酸光产物作为芳香烃受体(AHR)的内源性配体,芳香烃受体是一种经常被认为是外部刺激传感器的转录因子。除了紫外线,饮食化合物或毒素,其中许多被称为SLE的危险因素,代表AHR配体,因此,转录的激活与自身免疫性疾病有关。为了研究AHR在系统性自身免疫中的作用,我们产生了SLE的小鼠模型(K14-CD 40 L TG小鼠),其模拟人类疾病的典型特征,包括自身免疫性皮炎、肾炎、血清中的自身抗体和自身反应性T细胞的存在。有趣的是,AHR信号传导对于疾病发展至关重要,因为在AHR缺陷背景下繁殖的K14-CD 40 L TG小鼠没有显示出SLE样自身免疫的任何症状。AHR的细胞类型特异性缺失显示,T细胞中的AHR信号传导似乎与CD 40 L诱导的自身免疫的发病无关,而Langerin+树突状细胞(DC)中AHR缺陷的小鼠完全免受疾病的影响,这表明AHR在组织驻留DC中的核心作用。因此,我们假设AHR可能通过调节免疫细胞如组织驻留DC的功能而关键地参与(系统性)自身免疫性疾病的发展和进展。现在,我们将试图更好地了解自身免疫发病过程中AHR信号的配体和细胞特异性特征,并解决三个中心问题:(1)AHR信号对自身免疫发生和进展的影响以及自身反应细胞中该途径的功能相关性;(2)干预AHR信号作为潜在的治疗选择,自身免疫性疾病的(辅助)治疗;(3)AHR途径与致病性或自身反应性人类细胞发育的相关性。总之,该项目旨在更好地了解自身免疫过程中的AHR相互作用,这可能导致使用这种可药物化的配体激活的转录因子作为局部或辅助治疗自身免疫性疾病的分子靶点的新策略。
英文摘要
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease affecting many organs including the skin, the joints, the central nervous system or the kidneys. Although the pathophysiology of SLE is not completely understood yet, it has been shown that the interaction of impaired apoptotic clearance, up-regulated innate and adaptive immune responses, complement activation, autoantibodies, and imbalanced production of pro-inflammatory cytokines including type-1 interferons leads to the loss of self-tolerance. The onset of SLE requires a combination of genetic predisposition, environmental triggers, and immunological as well as hormonal factors. Among the environmental triggers of SLE, ultraviolet (UV) light is the most recognized one. UV irradiation contributes to the generation of tryptophan photoproducts, which act as endogenous ligands of the aryl hydrocarbon receptor (AHR), a transcription factor frequently suggested as sensor of external stimuli. Besides UV, dietary compounds or toxins, many of which are known as risk factors of SLE, represent AHR ligands and thus, activation of the transcription has been linked to autoimmune disorders. To investigate the role of AHR in systemic autoimmunity we generated a mouse model for SLE (K14-CD40L TG mice), which mimics typical characteristics of human disease including autoimmune dermatitis, nephritis, autoantibodies in the serum, and the presence of autoreactive T cells. Interestingly, AHR signaling was critical for disease development since K14-CD40L TG mice bred to an AHR-deficient background did not show any symptoms of SLE-like autoimmunity. Cell type-specific deletion of AHR revealed that AHR signaling in T cells seemed to be of minor relevance for the onset of CD40L-induced autoimmunity whereas mice deficient for AHR in Langerin+ dendritic cells (DC) were completely protected from disease, suggesting a central role of AHR in tissue-resident DC. Hence, we hypothesized that AHR might be critically involved in the development and progression of (systemic) autoimmune diseases by modulating the function of immune cells such as tissue-resident DC. Now we will try to better understand the ligand- and cell-specific character of AHR signaling during the onset of autoimmunity and three central questions shall be addressed: (1) Impact of AHR signaling on the development and progression of autoimmunity as well as functional relevance of the pathway in autoreactive cells; (2) Intervention in AHR signaling as potential therapeutic option for an (adjuvant) treatment of autoimmune diseases; (3) Relevance of the AHR pathway for the development of pathogenic or autoreactive human cells. Taken together, the project aims at better understanding AHR interactions in autoimmune processes, which might result in novel strategies to use this druggable ligand-activated transcription factor as a molecular target for the local or adjuvant treatment of autoimmune diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of 4-1BB/4-1BB ligand signaling on neuroimmune communication and the development of skin inflammation
  • 批准号:
    425988903
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2019
  • 负责人:
    Professorin Dr. Karin Loser
  • 依托单位:
Drugs from bugs: YopM - a bacteria-derived anti-inflammatory cell-penetrating peptide for the topical treatment of psoriasis
  • 批准号:
    258026263
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2014
  • 负责人:
    Professorin Dr. Karin Loser
  • 依托单位:
Relevance of RANK-RANKL signaling in cutaneous infectious diseases
  • 批准号:
    75670674
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2008
  • 负责人:
    Professorin Dr. Karin Loser
  • 依托单位:
Novel kappa-Opioid Receptor Agonists for the Treatment of Neuroinflammation
国内基金
海外基金
超对称可积系统:master对称、Cartan-Maurer方程
  • 批准号:
    11505284
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2015
  • 负责人:
    田凯
  • 依托单位:
分段Koszul代数和Calabi-Yau代数的相关研究
  • 批准号:
    11001245
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    18.0万元
  • 批准年份:
    2010
  • 负责人:
    吕家凤
  • 依托单位: